Pharmaceuticals for the treatment of metabolic, endocrine, gastrointestinal, and liver diseases and disorders

pharmaceutical research and development; pharmaceutical products development; research and development in the field of pharmaceutical drug development and discovery regarding the treatment of metabolic, endocrine, gastrointestinal, and liver diseases and disorders; pharmaceutical research regarding treatment of irritable bowel syndrome, inflammatory bowel disease, and non-alcoholic steatohepatitis (NASH)

Pharmaceuticals for the treatment of metabolic, endocrine, gastrointestinal, and liver diseases and disorders

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders